Wegovy (semaglutide) is MHRA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions like hypertension, alongside diet and exercise. Clinical trials (e.g., STEP-1) show 14.9–15% average weight loss over 68 weeks. It’s safe when prescribed by a UK clinician and monitored.

How does Wegovy compare to other weight loss drugs in the UK, like Mounjaro or Saxenda?
Wegovy, a GLP-1 receptor agonist, achieves 15% average weight loss over 68 weeks, less than Mounjaro (tirzepatide, 20–22.5%) but more than Saxenda (liraglutide, 5–10%). Side effects (e.g., gastrointestinal) are similar across all three, but Wegovy has more UK long-term safety data than Mounjaro. We can advise on the best choice for you.

Wegovy is suitable for UK adults with a BMI ≥30 or ≥27 with weight-related conditions, combined with diet and exercise. It’s effective but carries risks like nausea or, rarely, pancreatitis. A UK clinician must assess your health to confirm suitability, especially if you have no other medical conditions.

Purchasing Wegovy from unregulated online sources risks counterfeit or unsafe products. from unregulated online sources risks counterfeit or unsafe products. Reputable UK online pharmacies like Pharma Valley require a review & medical consultation. You can verify our pharmacy is registered with the General Pharmaceutical Council (GPhC). It is advised to ensure a reputable source to avoid scams.

Common side effects (nausea, diarrhoea, constipation) are typically mild and decrease over weeks, particularly with gradual dose increases. They may affect work or social activities initially. Rare serious risks, like pancreatitis, require urgent NHS care. Discuss potential impacts with our clinicians to balance benefits and risks.

Wegovy delivers 14.9% average weight loss over 68 weeks with lifestyle changes, compared to 2.4% for placebo with diet and exercise in trials. Non-medication methods, like Slimming World or NHS weight loss programmes, typically yield 5–10% weight loss and are slower. Wegovy requires ongoing use for sustained results.

Can I trust online reviews and testimonials about Wegovy in the UK?
UK reviews (e.g., Boots Online Doctor) report 5–15 kg weight loss and improved wellbeing, but reviews can be biased or fake. Social media posts may exaggerate results. Verify claims with clinical trial data and consult our clinicians to avoid misinformation. On our site we only use data from highly regarded trials and authentic review.

Wegovy may interact with medications like oral contraceptives, reducing their efficacy, or exacerbate conditions like severe gastrointestinal disorders. It’s not recommended for those with a history of medullary thyroid cancer or pancreatitis. Our UK clinicians will review your medical history to ensure safety.

Wegovy requires ongoing use with diet and exercise to maintain weight loss. Trials show weight regain is common after stopping without lifestyle maintenance. Consider the commitment and costs (~£110–£200/month via UK pharmacies, depending on dose) before starting. Our clinicians can help plan for sustainability.